PATENT CLAIM ANALYSIS

Application Number: 15951684
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "254110"]

Abstract:
Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.

Claim (Index 7):
The method according to  claim 6 , wherein the eltoprazine or a pharmaceutically acceptable acid or salt thereof is administered in an amount of from about 0.1 mg/day to about 10 mg/day.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.52632
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15409775', '14552298', '11219416', '10199634', '15409655']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753220052589398
- 35 USC 102 Novelty (BERT): 0.5425632812307404
- Combined Prediction Score: 0.7520461328561199
- Mean Citation Score: 346.240884
- Max Citation Score: 398.10803
- Similarity Product: 284.456283040396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test